Author

A. Rockstroh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

C. C. Nelson· 3 shared M. C. Sadowski· 2 shared M. Lehman· 2 shared A. Anand· 1 shared A. Gupta· 1 shared A. Jain· 1 shared A. Majumdar· 1 shared A. T. Fard· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

C. C. Nelson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Valine Catabolism Drives Bioenergetic and Lipogenic Fuel Plasticity in Prostate Cancer

C. L. Bidgood, L. K. Philp, A. Rockstroh, M. Lehman, C. C. Nelson, M. C. Sadowski, J. H. Gunter

This study identifies valine catabolism as a key driver of bioenergetic and lipogenic flexibility in prostate cancer, with potential therapeutic implications.

bioRxiv · Jan 1, 2024 · PreprintCancer Biology

Gene expression based inference of drug resistance in cancer

S. Chawla, A. Rockstroh, M. Lehman, E. Rather, A. Jain, A. Anand, A. Gupta, N. Bhattacharya, S. Poonia, P. Rai, N. Das, A. Majumdar, J. Jayadeva, G. Ahuja, B. G. Hollier, , D. Sengupta

This study uses gene expression data and machine learning to predict drug resistance in cancer by analyzing pathway activity patterns rather than gene expression levels alone.

bioRxiv · Nov 17, 2021Cancer Biology

Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer

K. D. Tousignant, A. Rockstroh, B. L. J. Poad, A. Talebi, R. R. S. Young, A. T. Fard, R. Gupta, T. Zang, C. Wang, M. L. Lehman, J. V. Swinnen, S. J. Blanksby, C. C. Nelson, M. C. Sadowski

This study identifies therapy-induced lipid uptake and remodeling as drivers of ferroptosis hypersensitivity in prostate cancer, offering new strategies to combat drug resistance.

bioRxiv · Jan 8, 2020Cancer Biology